Your First Steps with Sjögren-Larsson Syndrome
At a Glance
Sjögren-Larsson Syndrome (SLS) is a rare genetic condition characterized by a "classic triad" of symptoms: dry, scaly skin (ichthyosis), muscle stiffness (spasticity), and intellectual disability. It is caused by an ALDH3A2 gene mutation and requires coordinated care from multiple specialists.
Receiving a diagnosis of Sjögren-Larsson Syndrome (SLS) is a profound and often devastating moment. It is completely normal to feel grief, fear, and overwhelm, especially since you may have never heard the name before. It is an exceptionally rare condition, affecting approximately 0.4 per 100,000 individuals worldwide [1]. Because of its rarity, it is common for families to find that local doctors have limited experience with the syndrome [2]. This guide is designed to help you ground yourself in the facts, understand the biological journey ahead, and advocate for your child’s best possible care.
While SLS is a lifelong genetic condition without a cure, it is important to know that many symptoms are manageable [3]. Modern medicine offers treatments to improve skin comfort, enhance mobility, and support developmental progress [4][5]. Connecting with rare disease advocacy groups and other families who understand this unique journey can help remind you that you are not alone.
Understanding the “Classic Triad”
SLS is typically identified by three core features, often referred to as the “classic triad”:
- Congenital Ichthyosis: This is dry, thickened, and scaly skin that is usually present from birth [2][6].
- Spasticity: This refers to stiff or tight muscles, which may affect the legs (spastic diplegia) or all four limbs (spastic tetraplegia) [1]. These symptoms often become more apparent in the first two years of life [7].
- Intellectual Disability: Children with SLS typically face some degree of developmental delay or learning challenge [8].
Additionally, a significant number of children with SLS (approximately 59% to 73%) are born prematurely [9]. This is believed to be related to how the body processes fats during pregnancy [9].
The Science: Why SLS Happens
SLS is caused by mutations in the ALDH3A2 gene [8]. This gene is responsible for creating an enzyme called FALDH (fatty aldehyde dehydrogenase) [10].
Think of the FALDH enzyme as a specialized “cleanup crew” for the body [11]. Its job is to break down specific fatty substances called fatty aldehydes [12]. In children with SLS, this cleanup crew is either missing or doesn’t work correctly, leading to a toxic buildup of these fatty aldehydes [12][13].
- In the skin: This buildup disrupts the protective barrier, causing the dryness and scaling of ichthyosis [12].
- In the nervous system: The buildup interferes with myelin—the protective coating around nerve fibers—leading to muscle stiffness and developmental challenges [12].
What Research Tells Us
Researchers agree on the genetic cause and the biological “cleanup” failure described above [10]. However, one area that remains uncertain is the variability of the condition. Even within the same family, one child may have very mild symptoms while another is more severely affected [14][2]. Scientists are still working to understand why the same genetic mutation can lead to such different experiences [15].
Navigating the Road Ahead
Your child’s care will require a deeply coordinated, multidisciplinary effort. This guide is broken down into specific sections to help you navigate every stage of your child’s journey:
Recognizing the Symptoms of Sjögren-Larsson Syndrome
Learn to recognize the symptoms of Sjögren-Larsson Syndrome (SLS). Understand the classic triad of ichthyosis, spasticity, and intellectual disability.
The Biology and Diagnosis of Sjögren-Larsson Syndrome
Learn about the biology and diagnosis of Sjögren-Larsson Syndrome (SLS). Understand the ALDH3A2 gene, FALDH enzyme, MRI results, and pathology reports.
Managing SLS: Standard of Care and Treatments
Learn about standard treatments for Sjögren-Larsson Syndrome (SLS). Explore management options for skin symptoms, spasticity, dietary needs, and new research.
Building Your Child's Care Team for SLS
Learn how to build a multidisciplinary care team for your child with Sjögren-Larsson Syndrome (SLS). Discover which specialists you need and what to ask them.
Long-Term Outlook and Daily Life with SLS
Learn what to expect for the long-term outlook of Sjögren-Larsson Syndrome (SLS). Understand life expectancy, daily care needs, and ongoing monitoring.
Focusing on these manageable aspects step-by-step can help provide stability as you navigate this new diagnosis.
Common questions in this guide
What is the classic triad of Sjögren-Larsson Syndrome?
What causes Sjögren-Larsson Syndrome?
Is there a cure for Sjögren-Larsson Syndrome?
Why does Sjögren-Larsson Syndrome cause muscle stiffness?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the current status of my child’s ALDH3A2 gene activity, and how does this affect their prognosis?
- 2.How frequent should our follow-ups be with neurology, dermatology, and ophthalmology to monitor the 'classic triad'?
- 3.What specific moisturizing or exfoliating agents do you recommend for managing my child's ichthyosis on a daily basis?
- 4.Can you explain the results of my child’s MRI or MRS in relation to their muscle stiffness (spasticity)?
- 5.Are there any local specialists or support networks you work with who have experience managing SLS?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.
Abdel-Hamid MS, Issa MY, Elbendary HM, et al.
Journal of human genetics 2019; (64(9)):859-865 doi:10.1038/s10038-019-0637-x.
PMID: 31273323 - 2
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Amr K, El-Bassyouni HT, Ismail S, et al.
Archives of dermatological research 2019; (311(9)):721-730 doi:10.1007/s00403-019-01953-6.
PMID: 31388754 - 3
Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
Roy U, Das U, Pandit A, Debnath A
BMJ case reports 2016; (2016()):10.1136/bcr-2016-215110.
PMID: 27095813 - 4
Small touches to big walks -the impact of rehabilitation on Sjögren-Larsson syndrome: A case report.
Yolcu G, Huseynli L, Kenis-Coskun O, Karadag-Saygi E
Journal of pediatric rehabilitation medicine 2022; (15(3)):533-537 doi:10.3233/PRM-201521.
PMID: 35871376 - 5
Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
Vural S, Vural A, Akçimen F, et al.
International journal of dermatology 2018; (57(7)):843-848 doi:10.1111/ijd.14013.
PMID: 29704247 - 6
Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.
Kariminejad A, Barzgar M, Bozorgmehr B, et al.
European journal of medical genetics 2018; (61(3)):139-144 doi:10.1016/j.ejmg.2017.11.006.
PMID: 29183715 - 7
A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.
Warrack S, Love T, Rizzo WB
Journal of child neurology 2021; (36(11)):1011-1016 doi:10.1177/08830738211029390.
PMID: 34315315 - 8
Sjögren-Larsson syndrome: a complex metabolic disease with a distinctive ocular phenotype.
Fouzdar-Jain S, Suh DW, Rizzo WB
Ophthalmic genetics 2019; (40(4)):298-308 doi:10.1080/13816810.2019.1660379.
PMID: 31512987 - 9
Understanding fetal factors that contribute to preterm birth: Sjögren-Larsson syndrome as a model.
Staps P, Hogeveen M, Fuijkschot J, et al.
Journal of perinatal medicine 2018; (46(5)):523-529 doi:10.1515/jpm-2017-0187.
PMID: 28915122 - 10
Genotype and phenotype variability in Sjögren-Larsson syndrome.
Weustenfeld M, Eidelpes R, Schmuth M, et al.
Human mutation 2019; (40(2)):177-186 doi:10.1002/humu.23679.
PMID: 30372562 - 11
Ciliopathy: Sjögren-Larsson Syndrome.
Tsang SH, Aycinena ARP, Sharma T
Advances in experimental medicine and biology 2025; (1467()):195-196 doi:10.1007/978-3-031-72230-1_36.
PMID: 40736838 - 12
Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.
Liu YD, Lin HJ, Li CY, et al.
The International journal of neuroscience 2020; (130(11)):1156-1160 doi:10.1080/00207454.2020.1716750.
PMID: 31944864 - 13
Disturbed brain ether lipid metabolism and histology in Sjögren-Larsson syndrome.
Staps P, Rizzo WB, Vaz FM, et al.
Journal of inherited metabolic disease 2020; (43(6)):1265-1278 doi:10.1002/jimd.12275.
PMID: 32557630 - 14
Sjögren-Larsson syndrome: The mild end of the phenotypic spectrum.
Staps P, van Gaalen J, van Domburg P, et al.
JIMD reports 2020; (53(1)):61-70 doi:10.1002/jmd2.12099.
PMID: 32395410 - 15
Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
Cho KH, Shim SH, Kim M
Clinical genetics 2018; (93(4)):721-730 doi:10.1111/cge.13058.
PMID: 28543186
This guide provides educational information for families facing a new Sjögren-Larsson Syndrome diagnosis. It does not replace professional medical advice from your child's neurology, dermatology, and genetics care team.
Get notified when new evidence is published on Sjögren-Larsson syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.